Contract: 18-24 month fixed term contract
Hours of work: 37.5
Location: Remote home working/ hybrid
Galen is a privately owned pharma company with commercial operations in the UK and Europe and a network of partners serving global markets. Particular areas of focus include emergency care, gastroenterology and medical nutrition. We are always looking out for new markets and opportunities toward fulfilling our vision of creating a truly international pharmaceutical company from our base in Northern Ireland.
Our expertise lies in:
- Sales, marketing and launch excellence
- Market access
- Regulatory affairs, pharmacovigilance and medical affairs
- Supply chain and logistics
We are seeking a Senior Project Lead to manage an exciting new drug development programme for Galen. The project itself, whilst in the early stages, centres around a drug device combination product. The role holder will be responsible for managing the smooth running of all internal and external development aspects of the programme, including stakeholder management and will provide the necessary oversight and coordination needed to drive the project forward.
(For full details of essential and desirable criteria, please refer to the job description and person specification)
Along with a third level qualification, and a can-do attitude teamed with commercial acumen, the successful candidate should have previous experience in a pharmaceutical project role and have familiarity with the requirements of a pharmaceutical development programme. Previous experience of working within a drug device development project is highly desirable.
To apply, please attach your CV ensuring you demonstrate how you meet the skills and experience required for the role.
Please note this role is initially being offered on an 18-24 month fixed term contract and can be based remotely/ offer hybrid working depending on where the successful candidate is located.
Closing date for receipt of applications: 5pm, Monday 9th October 2023
Please note CVs will be assessed on an ongoing basis and we reserve the right to close this advert early if necessary.